Please login to the form below

Not currently logged in
Email:
Password:

memantine

This page shows the latest memantine news and features for those working in and with pharma, biotech and healthcare.

Roche and Evotec’s Alzheimer’s drug ineffective

Roche and Evotec’s Alzheimer’s drug ineffective

disease – the cholinesterase inhibitors donepezil, galantamine and rivastigmine or glutamate NMDA receptor antagonist memantine.

Latest news

More from news
Approximately 0 fully matching, plus 32 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics